Clinical Trial Update: Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of chemoradiation followed by the VIPD regimen for extranodal NK/T-cell lymphoma, nasal type, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• IFOSFAMIDE (IFOSFAMIDE)
• Vincristine (vincristine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Lymphoma, T-Cell | Phase 2 | Status: COMPLETED